Covalent Bruton tyrosine kinase inhibitors (BTKis) have improved CLL management, but discontinuation due to adverse events ...

Here are the most-read “5 things” articles from 2025.

As therapy for chronic lymphocytic leukemia (CLL) continues to evolve, 2025 brought research, regulatory news, and expert ...

High risk of obstructive sleep apnea (OSA) is linked to a 40% increase in poor mental health outcomes, including depression ...

CXCL12 and CXCL13 are potential biomarkers for RSV bronchiolitis severity and recurrence risk, with elevated levels indicating severe cases and recurrent wheezing, respectively. RSV remains a major ...

The 30th European Hematology Association (EHA) Congress (EHA 2025), held in Milan, Italy, from June 12-15, 2025, continued ...